Omeros

$11.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-0.90%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Omeros and other stocks, options, and ETFs commission-free!

About OMER

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. Read More It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA. The listed name for OMER is Omeros Corporation Common Stock.

Employees
258
Headquarters
Seattle, Washington
Founded
1994
Market Cap
678.67M
Price-Earnings Ratio
Dividend Yield
Average Volume
688.20K
High Today
$11.51
Low Today
$10.67
Open Price
$11.10
Volume
890.96K
52 Week High
$25.46
52 Week Low
$8.50

Collections

OMER Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 9, After Hours

You May Also Like